Fuse Medical Business Summary

Fuse Medical, Inc. (FZMD) is a manufacturer and distributor of medical devices that generates revenue through the direct sale and wholesale distribution of orthopedic implants and biologics to hospitals, medical facilities, and sub-distributors. The company operates as a single reporting segment but maintains a high-density product portfolio divided into Orthopedic Implants—encompassing internal and external fixation, total joint reconstruction, sports medicine, and spinal systems—and Biologics, which includes human allografts, regenerative tissues, and synthetic bone materials. In a market dominated by large-cap conglomerates like Stryker Corporation, Zimmer Biomet Holdings, Globus Medical, and Medtronic, Fuse Medical positions itself as an emerging, agile provider of cost-effective, specialized surgical solutions and innovative product launches like the Sterizo™ Tibial Revision Knee System. The company is led by a seasoned executive team with deep industry pedigree, primarily anchored by CEO and Secretary Christopher C. Reeg and Chairman and President Mark W. Brooks, who together acquired a controlling 57% stake in the firm in 2016. Reeg previously founded Maxim Surgical, a spinal implant manufacturer, while Brooks served as CEO of CPM Medical Consultants, bringing over 50 years of combined experience in the ancillary healthcare market. The leadership team also includes CFO and Treasurer Lawrence S. Yellin, a CPA with over 25 years of financial management experience in the medical and consumer sectors. The board is further strengthened by independent director Dr. Renato V. Bosita Jr., a fellowship-trained orthopedic spine surgeon, ensuring clinical expertise is integrated into the company’s strategic growth and product development initiatives.